Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic GastritisAndrew R. Moore, D. Mark Pritchard|PLoS ONE|2013Cited by 62
Correction: Netazepide, a Gastrin Receptor Antagonist, Normalises Tumour Biomarkers and Causes Regression of Type 1 Gastric Neuroendocrine Tumours in a Nonrandomised Trial of Patients with Chronic Atrophic GastritisAndrew R. Moore, D. Mark Pritchard|PLoS ONE|2013Cited by 8